OR WAIT null SECS
Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.
The need for preclinical testing expertise is growing as molecular complexity increases.
A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.
September 30, 2010
Novartis Sells US Enablex Rights; Ricerca Names Chemistry Director; And More.
September 23, 2010
DSM and PolyTherics in Development Deal; Kite Pharma Appoints President and CEO, And More.
September 16, 2010
Genzyme Sells Genetics Business; Bausch and Lomb Names Vice-President; and More.
Last week, Lonza (Basel) agreed to support the ongoing development of GlaxoSmithKline?s (GSK, London) biopharmaceutical pipeline by supplying manufacturing capacity for five early-stage monoclonal antibodies.
September 09, 2010
Pfizer to Acquire FoldRx; Protalix Appoints COO; And More.
Roche (Basel) launched a groupwide operational-excellence initiative intended to modify the company's cost structures and accelerate its productivity improvements.
September 02, 2010
Weighing the pros and cons of REMS for bringing risky products to market.
Company and People Notes: Lonza Acquired Vivante; PPD Appoints VP of Quality Management; And More.
A look at why Brazil revised its GMP standards and how the changes will affect the local pharmaceutical industry.
Pending legislation may give FTC the authority to regulate all Hatch-Waxman settlements.